Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
Evaluation of the new Axonics External Trial System (ETS-02) in patients with overactive bladder (OAB) and/or fecal incontinence (FI).
18 years or older [+2]
Any participant that the study Investigator deems to be a poor candidate for any... [+3]
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Participants aged ≥ 18 years at the time of enrollment [+3]
Any patient that is not a suitable candidate per investigator discretion [+9]
Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.
18 years or older [+2]
Any significant medical condition that is likely to interfere with study procedu... [+4]
Evaluation of the new Axonics External Trial System (ETS-02) in patients with overactive bladder (OAB) and/or fecal incontinence (FI).
18 years or older [+2]
Any participant that the study Investigator deems to be a poor candidate for any... [+3]
Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.
18 years or older [+2]
Any significant medical condition that is likely to interfere with procedures, d... [+5]
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Participants aged ≥ 18 years at the time of enrollment [+3]
Any patient that is not a suitable candidate per investigator discretion [+9]